Jury Reaches Defense Verdict for J&J at Conclusion of Bifurcated Talcum Powder Trial
September 24, 2021
DOCUMENTS
- Verdict Sheet
PHILADELPHIA –– Jurors have reached a defense verdict in favor of Johnson & Johnson and Johnson & Johnson Consumer Inc. at the conclusion of a bifurcated talcum powder trial, rejecting the plaintiff’s claims that she developed ovarian cancer as a result of using the defendants’ talcum powder products.
The Pennsylvania Court of Common Pleas for Philadelphia County jury reached the verdict just moments ago, completing a trial that kicked off on Aug. 18.
According to the verdict sheet, jurors found that the plaintiffs had not proven by a preponderance of the evidence that Johnson & Johnson’s Baby Powder was a …
UPCOMING CONFERENCES
HarrisMartin’s Artificial Stone Silicosis Epidemic Litigation Conference
January 10, 2025 - Long Beach, CA
The Westin Long Beach